Kidney International, Vol. 61 (2002), pp. 1814­1820
Bone mineral density is not diminished by mild to moderate
chronic renal insufficiency
CHI-YUAN HSU, STEVEN R. CUMMINGS, CHARLES E. MCCULLOCH, and GLENN M. CHERTOW
Division of Nephrology, Prevention Science Group, and Division of Biostatistics, University of California, San Francisco,
San Francisco, California, USA
Bone mineral density is not diminished by mild to moderate stage renal disease (ESRD) dialysis patients have re-
chronic renal insufficiency duced bone mineral density (BMD) and increased hip
Background. Persons with end-stage renal disease are at
fracture rates [2, 3]. Patients with CRI may also have
higher risk for osteopenia and hip fracture relative to the age-
reduced BMD as a result of abnormalities in acid-base
matched general population. Persons with mild to moderate
chronic renal insufficiency (CRI) may have reduced bone min- and vitamin D-parathyroid hormone (PTH) homeo-
eral density (BMD) as a result of abnormalities in acid-base stasis.
and vitamin D-parathyroid hormone homeostasis.
Metabolic acidosis, as indicated by decreased serum
Methods. We analyzed data on 13,848 adults aged 20 and
bicarbonate, has been detected by some investigators
above from the Third National Health and Nutrition Examina-
tion Survey (NHANES III; 1988­1994). Regression models with even modest reductions in GFR [4]. Chronic meta-
were used to determine the relationship between femoral BMD bolic acidosis may lead to bone buffering and slow disso-
and renal function, the latter assessed using serum creatinine,
lution of bone mineral [5]. Short-term oral administra-
blood urea nitrogen or Cockcroft-Gault creatinine clearance.
tion of bicarbonate in postmenopausal women improves
To control for confounding, we fit sex-stratified models that
adjusted for age, weight, height, race-ethnicity, menopausal calcium and phosphorus balance and reduces bone re-
status, estrogen use, activity level, family history of osteoporo- sorption [6].
sis, diuretic use, and dietary intake of calcium and alcohol.
Many persons with mild to moderate CRI also have
Results. Although subjects with reduced renal function had
decreased serum 1,25(OH)2
vitamin D and increased
significantly lower femoral BMD in unadjusted analysis, the
association between CRI and bone mineral density was extin- PTH levels [7] and their bone biopsies show evidence
guished after adjustment in the multivariate models. In fact, of PTH excess and increased bone turnover [8]. Bio-
controlling for only sex, age and weight was sufficient to extin-
chemical markers of bone turnover have been found to
guish any negative association between decreased renal func-
correlate with PTH levels and GFR [9]. A low 1,25(OH)2
tion and decreased bone mineral density.
Conclusion. Although subjects with worse renal function vitamin D level is an independent risk factor for hip
have significantly lower femoral BMD, this association can be fractures [10].
explained by confounding, principally by sex, age and weight.
Several previous studies have found that persons with
After taking into account the facts that women, older individu-
CRI have decreased BMD [9, 11­16]. These studies have
als and smaller individuals have less renal function and lower
BMD, renal function itself is not independently associated with been limited by small sample sizes, lack of racial or ethnic
BMD. diversity and, perhaps most importantly, failure to adjust
adequately for some key confounders such as sex, age
and weight [9, 11­16]. The generalizability of these find-
There is increasing interest in understanding and treat- ings to persons with CRI in the general population (that
ing the consequences of chronic renal insufficiency is, those not necessarily seen by nephrologists or endocri-
(CRI), defined here as reduced glomerular filtration rate nologists) is also unclear. It is important to test rigorously
(GFR) not requiring renal replacement therapy [1]. End- the hypothesis that reduced renal function is an indepen-
dent risk factor for decreased BMD given that 6.2 million
Americans are estimated to have serum creatinine 1.5
Key words: NHANES III, glomerular filtration rate, creatinine clear-
ance, chronic kidney disease, osteopenia, osteoporosis. mg/dL [17] and osteoporosis and hip fractures are major
clinical and public health problems.
Received for publication September 26, 2001
In this study, we used nationally representative data
and in revised form December 4, 2001
Accepted for publication December 5, 2001 from Third National Health and Nutrition Examination
Survey (NHANES III) (1988­1994) to determine the in-
 2002 by the International Society of Nephrology
1814
Hsu et al: Bone mineral density in CRI 1815
dependent relationship between renal function and fem- Assessment of co-variates
oral BMD after adjusting for potential confounders. In addition to sex, age and weight, other co-variates
were considered that have been shown in large epidemio-
logical studies to predict femoral BMD [23]. These in-
METHODS
clude: height; race-ethnicity (pre-defined in NHANES
NHANES III population
III as non-Hispanic white, non-Hispanic black, Mexican-
The design and operation of NHANES III have been American, or other); level of physical activity (self re-
described [18]. Briefly, NHANES III provides cross-sec- ported as below average/average/above average); family
tional, nationally representative data on the health and history of osteoporosis (hip fracture or physician diagno-
nutritional status of the civilian, non-institutionalized sis of osteoporosis in biological mother); current use
U.S. population. To achieve this, a four-stage sampling of diuretics (thiazides and non-thiazides); and dietary
design was used: (1) primary sampling units (PSU) com- intake of calcium and alcohol. For women, we also con-
prising mostly of single counties, (2) area segments sidered menopausal status (last period 1 year ago) and
within PSUs, (3) households within area segments, and current use of estrogen (pill or patch). Data were ob-
(4) persons within households. NHANES III oversampled tained from NHANES III patient interview and 24-hour
older persons, Mexican Americans, and non-Hispanic dietary recall [18].
blacks to obtain reliable estimates in these subgroups.
Statistical analysis
Measurement of bone mineral density
Statistical analysis was conducted using SAS v8.01
In NHANES III, 31,311 subjects were examined in (Cary, NC, USA). NHANES III was not a random sam-
the mobile examination center or at home. A trained ple of the U.S. population and not everyone had the
individual measured BMD of the proximal femur on same probability of selection. Appropriate sample weights
men and non-pregnant women aged over 20 years in were therefore used to obtain weighted regression esti-
the mobile examination center using dual energy X-ray mates from the sampled population. The sample weights
absorptiometry (DXA; Hologic QDR 1000, Waltham, also adjusted for non-coverage and non-response [24,
MA, USA). BMD was measured in several areas of the 25]. The final results of the analysis are thus broadly
proximal femur: femoral neck, trochanter, intertrochan- generalizable to the U.S. population.
ter, and total region. Excluded were subjects with bilat-
In our primary analysis, the relationship between cate-
eral hip fractures and hip pins or artificial hips. Details
gories of SCr
and BMD was determined in sex-stratified
of the BMD measurement and DXA quantity control
general linear models. In men, SCr
was categorized as
have been published [18­20]. 0.8, 0.9­1.0, 1.1­1.2 (reference), 1.3­1.4, 1.5­1.6, 1.7­
1.8, 1.9­2.0, 2.1­2.2 and 2.3 mg/dL. In women, SCr
was
Assessment of renal function
categorized as 0.6, 0.7­0.8, 0.9­1.0 (reference), 1.1­1.2,
All NHANES III participants over age 12 were eligible
1.3­1.4, 1.5­1.6, 1.7­1.8, 1.9­2.0, and 2.1 mg/dL.
for measurement of a biochemistry profile that included
We then adjusted for age, weight, height, race-eth-
serum creatinine (SCr
) and blood urea nitrogen (BUN).
nicity, activity level, family history of osteoporosis, di-
Excluded from venipuncture were examinees reporting
uretic use and dietary intake of calcium and alcohol in
hemophilia or recent cancer chemotherapy treatment
sex-stratified multivariate models. For women, we also
[21].
adjusted for menopausal status and estrogen use.
The measure of renal function in our primary analysis
We postulated a priori that sex, age and weight were
was SCr
. In secondary analyses, renal function was as-
the most important potential confounders of any associa-
sessed using BUN (adjusted for dietary protein) and
tion between renal function and BMD. Therefore sex-
Cockcroft-Gault equation creatinine clearance (CCr
)
stratified analyses were performed in which terms for
[22].
age and weight were entered both as categorical vari-
CCr
(mL/min)  (Eq. 1)
ables (10-year and 10-kg increments) and as continuous
variables. The former obviated the need to assume that
(140  age)  wt (kg)
SCr
(mg/dL)  72
( 0.85 for females)
BMD varied linearly with age or weight and the latter
controlled for any residual confounding within each age
or weight category.
We chose not to use Cockcroft-Gault CCr
in the pri-
In secondary analyses, BUN was used as a measure
mary analysis because interpretation of any observed
of renal function and categorized as 5, 6­10, 11­15
association between Cockcroft-Gault CCr
and BMD may
(reference), 16­20, 21­25, 26­30, 31­35, 36­40, and 41
be clouded by the fact that sex, age and weight, which
mg/dL. Since BUN is also affected by daily protein in-
are used to derive the Cockcroft-Gault CCr
, are three of
the most important independent correlates of BMD. take, we adjusted for dietary protein in all analyses using
Hsu et al: Bone mineral density in CRI
1816
BUN as the measure of renal function. When Cockcroft- have reduced BMD, this association can be explained
Gault CCr
was used, subjects were divided into eight by confounding by known predictors of BMD, princi-
categories [26, 27]: 80 (reference), 70 to 80, 60 pally sex, age and weight. After adjusting for these fac-
to 70, 50 to 60, 40 to 50, 30 to 40, 20 to tors, no independent association between renal function
30 and 20 mL/min. and BMD was found. To our knowledge, this is the
largest study testing the hypothesis that reduced renal
function is an independent risk factor for decreased
RESULTS
BMD. Since NHANES III is a nationally representative
NHANES III population sample, these results should be broadly generalizable.
There were 7132 women and 6716 men with techni- Previous studies showing that CRI is associated with
cally acceptable DXA scans and measured SCr
values. reduced BMD had several limitations, including lack of
The characteristics of the study population are described adequate adjustment for key confounders such as sex,
in Table 1. Since this study population was not a random age or weight [9, 11, 15]. For example, Rix et al found
sample of the U.S. population, prevalence of CRI shown that quartiles of GFR predicted BMD. However, 24 of
reflects not only the prevalence of CRI in the U.S. popu- 28 subjects in their best GFR quartile were men, com-
lation but also the effects of sampling as older persons, pared with 20 of 28 subjects in the middle two quartiles
Mexican-Americans and non-Hispanic blacks were in- and 18 of 28 subjects in the worse GFR quartile [9].
tentionally over-represented. (These groups were subse- Since men have significantly higher BMD than women,
quently weighted less in the regression analysis in order determining the independent association between GFR
for the final results to be broadly generalizable.) and BMD is problematic. Similarly, in a study of 36
women and 33 men with CRI by Bianchi et al, informa-
Femoral bone mineral density and renal function
tion on weight was not presented [15], although weight
Bone mineral density of femoral neck, trochanter re- strongly predicts both axial and appendicular bone mass
gion, intertrochanter region and total femoral region [23, 28].
were highly correlated (Pearson correlation coefficients The importance of confounding is confirmed in a study
0.85­0.98). by Buchanan et al of 19 postmenopausal Caucasian
In univariate analysis, both women and men with women. Although measured CCr
was significantly corre-
higher SCr
had lower femoral neck BMD (Table 2). How- lated with lumbar BMD (P  0.03), this relationship
ever, there was no significant relationship between SCr became non-significant (P  0.60) after age was entered
and BMD after adjusting for age, weight, height, race- into the model [12]. Similarly, Sherman et al found
ethnicity, activity level, family history of osteoporosis, among 311 mostly white subjects that there was no asso-
diuretic use, dietary intake of calcium and alcohol and, ciation between femoral neck, spine or radius BMD with
in women, menopausal status and estrogen use (Table measured CCr
after adjusting for age [14].
2). The expected independent association between these Our results suggest that although abnormalities in
other factors and BMD were all confirmed in our multi- acid-base and vitamin D-PTH homeostasis could be det-
variate models except in the cases of height and calcium rimental to bone mass, the magnitude of these effects
and alcohol intake (where P  0.05). Similar results were may be small, at least among persons with mild or moder-
obtained when we examined BMD of the trochanter, ate CRI. ESRD patients may suffer osteoporosis because
intertrochanter or total femoral regions (data not shown). of other risk factors not prevalent in the CRI population,
In univariate analyses, women and men with higher
such as immobilization and gonadal dysfunction [2].
BUN and lower Cockcroft-Gault CCr
values also had
The findings of the present report should be interpre-
lower femoral neck BMD (Tables 3 and 4). Again, how-
ted in the context of the study design. We do not have
ever, in multivariate analyses, neither BUN nor Cock-
information on bone histology. Malluche et al performed
croft-Gault CCr
was an independent predictor of BMD
bone biopsies on 50 subjects and found that osteoclastic
(Tables 3 and 4).
surface resorption was abnormally high when the GFR
In fact, in sex-stratified analyses, adjusting for age and
fell below 50 mL/min/1.73 m2 and endosteal fibrosis ap-
weight only was sufficient to extinguish any negative
peared below a GFR of 30 mL/min/1.73 m2 [8]. Few
association between femoral neck BMD and renal func-
other studies examined bone histology among CRI sub-
tion (assessed by SCr
, BUN or Cockcroft-Gault CCr
). Age
jects and little is known about how bone histology corre-
and weight themselves remained powerful independent
lates with BMD in this population.
predictors of BMD in all multivariate analyses.
Bone mineral density in NHANES III subjects was
measured only in the proximal femur and not elsewhere.
DISCUSSION This may explain in part why our results differ from
those of Yendt et al [13, 16], who studied 114 older white
In this study of 13,848 NHANES III examinees, we
found that although subjects with worse renal function women with SCr
1.3 mg/dL. These authors found that
Hsu et al: Bone mineral density in CRI 1817
Table 1. Characteristics of the NHANES III study population
Parameter Women (N  7132) Men (N  6716)
Age years 4819 4819
Weight kg 7117 8016
Height cm 1607 1738
Race-ethnicity (non-Hispanic white/non-Hispanic
black/Mexican-American/other) % 44/28/25/4 42/26/29/4
Post-menopausal 3411 (48%) --
Estrogen use 491 (7%) --
Activity level (below average/average/above average/
missing or unknown) % 24/46/29/2 17/45/36/2
Family history of osteoporosis 508 (7%) 365 (5%)
Diuretic use 803 (11%) 496 (7%)
Dietary intake of calcium mg/day 659440 876594
Dietary intake of alcohol g/day 417 1435
Femoral neck bone mineral density (BMD) g/cm2 0.790.17 0.880.17
BMD of trochanter region g/cm2 0.660.13 0.760.13
BMD of intertrochanter region g/cm2 1.050.21 1.180.20
BMD of total femoral region g/cm2 0.890.17 1.010.17
Serum creatinine mg/dL 1.00.3 1.20.4
Blood urea nitrogen mg/dL 146 156
Cockcroft-Gault CCr
mL/min 8231 8930
Number of subjects with
SCr
SCr
0.6 mg/dL 41 (1%) 0.8 mg/dL 83 (1%)
0.7­0.8 mg/dL 1498 (21%) 0.9­1.0 mg/dL 1390 (21%)
0.9­1.0 mg/dLa 3843 (54%) 1.1­1.2 mg/dLa 3186 (47%)
1.1­1.2 mg/dL 1316 (18%) 1.3­1.4 mg/dL 1427 (21%)
1.3­1.4 mg/dL 252 (4%) 1.5­1.6 mg/dL 373 (6%)
1.5­1.6 mg/dL 107 (2%) 1.7­1.8 mg/dL 132 (2%)
1.7­1.8 mg/dL 35 (0.5%) 1.9­2.0 mg/dL 48 (1%)
1.9­2.0 mg/dL 13 (0.2%) 2.1­2.2 mg/dL 23 (0.3%)
2.1 mg/dL 27 (0.4%) 2.3 mg/dL 54 (1%)
BUN
5 mg/dL 66 (1%) 42 (1%)
6­10 mg/dL 2005 (28%) 899 (13%)
11­15 mg/dLa 3154 (44%) 2948 (44%)
16­20 mg/dL 1324 (19%) 1920 (29%)
21­25 mg/dL 378 (5%) 632 (9%)
26­30 mg/dL 124 (2%) 158 (2%)
31­35 mg/dL 40 (1%) 56 (1%)
36­40 mg/dL 13 (0.2%) 27 (0.4%)
41 mg/dL 28 (0.4%) 34 (1%)
CCr
80 mL/mina 3468 (49%) 4137 (62%)
80  CCr
 70 mL/min 1040 (15%) 809 (12%)
70  CCr
 60 mL/min 861 (12%) 612 (9%)
60  CCr
 50 mL/min 700 (10%) 474 (7%)
50  CCr
 40 mL/min 529 (7%) 365 (5%)
40  CCr
 30 mL/min 365 (5%) 233 (3%)
30  CCr
 20 mL/min 149 (2%) 67 (1%)
CCr
 20 mL/min 20 (0.3%) 19 (0.3%)
All values are unweighted mean  standard deviation unless otherwise stated.
a Reference group
even after adjusting for age, body surface area and 24- group. Since it is among these individuals that the most
severe acid-base and vitamin D-PTH disturbances occur,
hour urine creatinine, measured CCr
was still indepen-
dently associated with radial bone mineral content and detrimental renal effects on BMD may develop late in
the disease process and further studies focusing on pa-
lumbar BMD. Yendt et al did not measure femoral BMD
[13, 16]. tients with advanced CRI are therefore needed.
Renal function was assessed using SCr
, BUN and Cock-
Given the small number of NHANES III participants
with advanced CRI (such as, close to requiring dialysis), croft-Gault CCr
since actual measurements of GFR were
not available. However, our "null" result is unlikely due
we have relatively little accuracy in studying this sub-
Hsu et al: Bone mineral density in CRI
1818
Table 2. Relationship between femoral neck bone mineral density (g/cm2) and categories of serum creatinine (SCr
)
Gender Unadjusted P value Adjusteda P value
Women
SCr
0.6 mg/dL 0.08 [0.18, 0.03] 0.16 0.05 [0.11, 0.01] 0.07
0.7­0.8 mg/dL 0.01 [0.02, 0.01] 0.54 0.01 [0.02, 0.00] 0.09
0.9­1.0 mg/dL reference reference
1.1­1.2 mg/dL 0.02 [0.04, 0.01] 0.003 0.00 [0.00, 0.01] 0.26
1.3­1.4 mg/dL 0.08 [0.11, 0.05] 0.0001 0.02 [0.00, 0.04] 0.08
1.5­1.6 mg/dL 0.13 [0.17, 0.10] 0.0001 0.02 [0.04, 0.01] 0.20
1.7­1.8 mg/dL 0.14 [0.19, 0.08] 0.0001 0.00 [0.05, 0.05] 0.97
1.9­2.0 mg/dL 0.14 [0.20, 0.08] 0.0001 0.07 [0.13, 0.01] 0.03
2.1 mg/dL 0.12 [0.23. 0.02] 0.03 0.04 [0.11, 0.04] 0.33
Men
SCr
0.8 mg/dL 0.03 [0.08, 0.03] 0.30 0.03 [0.09, 0.03] 0.29
0.9­1.0 mg/dL 0.00 [0.02, 0.01] 0.73 0.00 [0.02, 0.01] 0.74
1.1­1.2 mg/dL reference reference
1.3­1.4 mg/dL 0.01 [0.00, 0.03] 0.09 0.01 [0.00, 0.02] 0.14
1.5­1.6 mg/dL 0.01 [0.04, 0.03] 0.72 0.02 [0.01, 0.04] 0.14
1.7­1.8 mg/dL 0.05 [0.11, 0.01] 0.10 0.01 [0.02, 0.04] 0.58
1.9­2.0 mg/dL 0.13 [0.18, 0.07] 0.0001 0.02 [0.08, 0.03] 0.36
2.1­2.2 mg/dL 0.09 [0.22, 0.04] 0.18 0.02 [0.07, 0.12] 0.63
2.3 mg/dL 0.10 [0.16. 0.03] 0.003 0.01 [0.07, 0.05] 0.76
a Adjusted for age, weight, height, race-ethnicity, activity level, family history of osteoporosis, diuretic use, dietary intake of calcium and alcohol; and menopausal
status and estrogen use in women (values in brackets are 95% confidence intervals for parameter estimates)
Table 3. Relationship between femoral neck bone mineral density (g/cm2) and categories of blood urea nitrogen (BUN)
Unadjusted
Gender (except for protein intake) P value Adjusteda P value
Women
BUN 5 mg/dL 0.06 [0.01, 0.11] 0.02 0.01 [0.03, 0.04] 0.73
6­10 mg/dL 0.03 [0.02, 0.04] 0.0001 0.01 [0.02, 0.00] 0.26
11­15 mg/dL reference reference
16­20 mg/dL 0.06 [0.07, 0.05] 0.0001 0.00 [0.01, 0.01] 0.94
21­25 mg/dL 0.10 [0.12, 0.08] 0.0001 0.00 [0.02, 0.02] 0.77
26­30 mg/dL 0.15 [0.19, 0.12] 0.0001 0.02 [0.05, 0.01] 0.14
31­35 mg/dL 0.13 [0.18, 0.08] 0.0001 0.02 [0.01, 0.04] 0.22
36­40 mg/dL 0.20 [0.26, 0.13] 0.0001 0.03 [0.07, 0.01] 0.14
41 mg/dL 0.11 [0.20, 0.02] 0.02 0.02 [0.08, 0.04] 0.43
Men
BUN 5 mg/dL 0.01 [0.06, 0.08] 0.78 0.03 [0.02, 0.08] 0.22
6­10 mg/dL 0.00 [0.02, 0.01] 0.58 0.01 [0.03, 0.00] 0.06
11­15 mg/dL reference reference
16­20 mg/dL 0.02 [0.03, 0.01] 0.001 0.01 [0.00, 0.02] 0.11
21­25 mg/dL 0.03 [0.05, 0.01] 0.004 0.03 [0.01, 0.04] 0.004
26­30 mg/dL 0.08 [0.11, 0.05] 0.0001 0.02 [0.01, 0.05] 0.25
31­35 mg/dL 0.09 [0.16, 0.03] 0.006 0.02 [0.03, 0.06] 0.52
36­40 mg/dL 0.06 [0.12, 0.00] 0.05 0.08 [0.02, 0.13] 0.008
41 mg/dL 0.12 [0.17, 0.08] 0.0001 0.01 [0.03, 0.06] 0.62
a Adjusted for age, weight, height, race-ethnicity, activity level, family history of osteoporosis, diuretic use, dietary intake of protein, calcium and alcohol; and
menopausal status and estrogen use in women (values in brackets are 95% confidence intervals for parameter estimates)
to misclassification of renal function. We were able to is no independent association between renal function
and BMD.
confirm other investigators' finding that there was a
strong univariate association between BMD and renal To conclude, in a large study of nationally representa-
tive NHANES III participants, we found no evidence
function. Furthermore, using these three parameters of
renal function and the specific selected categories, we to support the hypothesis that decreased renal function
(with its attendant metabolic abnormalities) is an inde-
were previously able to demonstrate robust relationships
between renal function and hematocrit in both men and pendent risk factor for decreased BMD. This is in con-
trast to other adverse consequences of CRI, such as
women (although only the Cockcroft-Gault CCr
results
were reported) [26, 27]. This argues that within the con- decreased hematocrit, which can be readily detected
even among individuals with mild to moderate CRI
fidence intervals presented in Tables 2 to 4, there truly
Hsu et al: Bone mineral density in CRI 1819
Table 4. Relationship between femoral neck bone mineral density (g/cm2) and categories of creatinine clearance
Gender Unadjusted P value Adjusted* P value
Women
CCr
 80 mL/min reference reference
80  CCr
 70 mL/min 0.08 [0.09, 0.07] 0.0001 0.00 [0.01, 0.01] 0.65
70  CCr
 60 mL/min 0.10 [0.12, 0.09] 0.0001 0.02 [0.00, 0.03] 0.02
60  CCr
 50 mL/min 0.17 [0.19, 0.16] 0.0001 0.01 [0.01, 0.03] 0.17
50  CCr
 40 mL/min 0.23 [0.24, 0.21] 0.0001 0.01 [0.01, 0.03] 0.21
40  CCr
 30 mL/min 0.28 [0.30, 0.27] 0.0001 0.00 [0.02, 0.03] 0.78
30  CCr
 20 mL/min 0.31 [0.33, 0.29] 0.0001 0.01 [0.03, 0.04] 0.73
CCr
 20 mL/min 0.31 [0.36, 0.25] 0.0001 0.04 [0.09, 0.01] 0.12
Men
CCr
 80 mL/min reference reference
80  CCr
 70 mL/min 0.09 [0.11, 0.08] 0.0001 0.00 [0.01, 0.02] 0.63
70  CCr
 60 mL/min 0.11 [0.13, 0.09] 0.0001 0.02 [0.00, 0.05] 0.03
60  CCr
 50 mL/min 0.16 [0.18, 0.14] 0.0001 0.02 [0.01, 0.04] 0.25
50  CCr
 40 mL/min 0.18 [0.20, 0.15] 0.0001 0.02 [0.01, 0.05] 0.20
40  CCr
 30 mL/min 0.22 [0.24, 0.20] 0.0001 0.01 [0.03, 0.02] 0.56
30  CCr
 20 mL/min 0.23 [0.28, 0.17] 0.0001 0.01 [0.04, 0.07] 0.64
CCr
 20 mlLmin 0.06 [0.25, 0.13] 0.54 0.08 [0.07, 0.24] 0.30
a Adjusted for age, weight, height, race-ethnicity, activity level, family history of osteoporosis, diuretic use, dietary intake of calcium and alcohol; and menopausal
status and estrogen use in women (values in brackets are 95% confidence intervals for parameter estimates)
9. Rix M, Andreassen H, Eskildsen P, et al: Bone mineral density
[26, 27]. Whether the risk of hip fracture in persons with
and biochemical markers of bone turnover in patients with predial-
ESRD is related to an accelerated loss of BMD with ysis chronic renal failure. Kidney Int 56:1084­1093, 1999
10. Cummings SR, Browner WS, Bauer D, et al: Endogenous hor-
advanced CRI or to other unrelated factors (such as
mones and the risk of hip and vertebral fractures among older
propensity to fall) is unknown. Further studies are
women. N Engl J Med 339:733­738, 1998
needed to define fully the metabolic and functional con- 11. Berlyne GM, Ben-Ari J, Kushelevsky A, et al: The aetiology of
senile osteoporosis: Secondary hyperparathyroidism due to renal
sequences of CRI.
failure. Quart J Med 44:505­521, 1975
12. Buchanan JR, Myers CA, Greer RB: Effect of declining renal
ACKNOWLEDGMENTS function on bone density in aging women. Calcif Tissue Int 43:1­6,
1988
Drs. Hsu and Chertow are supported by the National Institutes of
13. Yendt ER, Cohanim M, Jarzylo S, et al: Bone mass is related to
Health (RO1 DK 58411 and K23 DK 61520). The authors thank Dr.
creatinine clearance in normal elderly women. J Bone Miner Res
Anthony Sebastian for his comments on earlier drafts of the manu-
6:1043­1050, 1991
script.
14. Sherman SS, Tobin JD, Hollis BW, et al: Biochemical parameters
associated with low bone density in healthy men and women. J
Reprint requests to Chi-yuan Hsu, M.D., M.Sc., Division of Nephrol-
Bone Miner Res 7:1123­1130, 1992
ogy, University of California, San Francisco, Room 672 HSE, 513 Par-
15. Bianchi ML, Colantonio G, Montesano A, et al: Bone mass
nassus Avenue, San Francisco, California 94143-0532, USA.
status in different degrees of chronic renal failure. Bone 13:225­228,
E-mail: hsuchi@medicine.ucsf.edu
1992
16. Yendt ER, Cohanim M, Jarzylo S, et al: Reduced creatinine
clearance in primary osteoporosis in women. J Bone Miner Res
REFERENCES
8:1045­1052, 1993
1. Hsu CY, Chertow GM: Chronic renal confusion: Insufficiency, 17. Jones CA, McQuillan GM, Kusek JW, et al: Serum creatinine
failure, dysfunction, or disease. Am J Kidney Dis 36:415­418, 2000 levels in the US population: Third National Health and Nutrition
2. Lindberg JS, Moe SM: Osteoporosis in end-state renal disease. Examination Survey. Am J Kidney Dis 32:992­999, 1998 [erratum]
Semin Nephrol 19:115­122, 1999 18. National Center for Health Statistics: Third National Health
3. Alem AM, Sherrard DJ, Gillen DL, et al: Increased risk of hip and Nutrition Examination Survey, 1988­1994, Plan and Operation
fracture among patients with end-stage renal disease. Kidney Int of the Third National Health and Nutrition Examination Survey,
58:396­399, 2000 1988­94 (CD-ROM) (revised 9/97). Hyattsville, MD, Center for
4. Frassetto LA, Morris RC Jr, Sebastian A: Effect of age on blood Disease Control and Prevention, 1996
acid-base composition in adult humans: Role of age-related renal 19. Looker AC, Johnston CC Jr, Wahner HW, et al: Prevalence of
functional decline. Am J Physiol 271:F1114­F1122, 1996 low femoral bone density in older U.S. women from NHANES
5. Lemann J Jr, Litzow JR, Lennon EJ: The effects of chronic acid III. J Bone Miner Res 10:796­802, 1995
20. Looker AC, Orwoll ES, Johnston CC Jr, et al: Prevalence of
loads in normal man: Further evidence for the participation of
bone mineral in the defense against chronic metabolic acidosis. J low femoral bone density in older U.S. adults from NHANES III.
J Bone Miner Res 12:1761­1768, 1997
Clin Invest 45:1608­1614, 1966
6. Sebastian A, Harris ST, Ottaway JH, et al: Improved mineral 21. National Center for Health Statistics: Third National Health
and Nutrition Examination Survey, 1988­1994, Field Operations
balance and skeletal metabolism in postmenopausal women treated
with potassium bicarbonate. N Engl J Med 330:1776­1781, 1994 Reference Manuals (CD-ROM) (revised 9/97). Hyattsville, MD,
Center for Disease Control and Prevention, 1996
7. Pitts TO, Piraino BH, Mitro R, et al: Hyperparathyroidism and
1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe 22. Cockcroft DW, Gault MH: Prediction of creatinine clearance
from serum creatinine. Nephron 16:31­41, 1976
renal failure. J Clin Endocrinol Metab 67:876­881, 1988
8. Malluche HH, Ritz E, Lange HP, et al: Bone histology in incipi- 23. Orwoll ES, Bauer DC, Vogt TM, Fox KM: Axial bone mass in
older women. Ann Intern Med 124:187­196, 1996
ent and advanced renal failure. Kidney Int 9:355­362, 1976
Hsu et al: Bone mineral density in CRI
1820
24. National Center for Health Statistics: Third National Health between hematocrit and renal function in men and women. Kidney
Int 59:725­731, 2001
and Nutrition Examination Survey, 1988­1994, Analytic and Re-
porting Guidelines (CD-ROM) (revised 9/97). Hyattsville, MD, 27. Hsu CY, McCulloch CE, Curhan GC: Epidemiology of anemia
associated with chronic renal insufficiency among adults in the
Center for Disease Control and Prevention, 1996
25. National Center for Health Statistics: Third National Health Unites States: Results from NHANES III. J Am Soc Nephrol
13:504-510, 2002
and Nutrition Examination Survey, 1988­1994, Weighting and Esti-
mation Methodology (CD-ROM) (revised 9/97). Hyattsville, MD, 28. Bauer DC, Browner WS, Cauley JA, et al: Factors associated
with appendicular bone mass in older women. Ann Intern Med
Center for Disease Control and Prevention, 1996
26. Hsu CY, Bates DW, Kuperman GJ, Curhan GC: Relationship 118:657­665, 1993
